Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on April 24, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Optical Instrument and Lens Manufacturing / Mass Photometer

Awarded
NIAID-RFQ-20-2001482Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Contract Value

$107,300

NAICS

333314 - Optical Instrument and Lens Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Awardee

REFEYN INC

Award Issued Date

Documents

1

Terms++and+Conditions+NIAID+RFQ+20+2001482.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Combined Synopsis

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more
This notice is a combined synopsis/solicitation Request for Quotation NIAID-RFQ-20-2001482 for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued. The solicitation document and incorporated provisions and clauses are those in effect with the Federal Acquisition Circular 2020-05 dated March 30, 2020. The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VRC) is requesting to procure one (1) Mass Photometer with Analysis Software, Installation, one (1) day training with an additional three (3) day training, optional one (1) year service contract (one (1) - year extended warranty), and delivery. FAR Part 12 - Acquisition for Commercial Items, and FAR Part 13 - Simplified Acquisition Procedures will be used for this acquisition. Only one award will be made as a result of this solicitation. This acquisition will be awarded as a firm-fixed price type of contract, and is not a small business set-aside. The associated North American Industry Classification System (NAICS) Code is 333314, with the size standard of 500. Delivery to Bethesda, Maryland 20892 approximately 120 days after receipt and acceptance of award. The following apply to this acquisition: FAR Part 52.212-1 Instructions to Offerors - Commercial Items FAR Part 52.212-3 Offeror Representations and Certification - Commercial Items FAR Part 52.212-4 Contract Terms and Conditions - Commercial Items FAR Part 52.212-5 Contract Terms and Conditions Required to Implement Status or Executive Orders - Commercial Items (see attached) FAR Part 52.204-7 System for Award Management FAR Part 52.204-16 Commercial for Government Entity Code Reporting FAR Part 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services of Equipment FAR Part 52.232-40 Providing Accelerated Payments to Small Business and Subcontractors By reference the Department of Health and Human Services Acquisition Regulation (HHSAR) 352.203-70 Anti-lobbying 352.222-70 - Contractor Cooperation in Equal Employment Opportunity Investigations 352.239-73 Electronic and Information Technology Accessibility Notice. The NIAID, VRC focuses on vaccine development for HIV-1 and other infectious diseases. Production of various wild type and mutant viral proteins and anti-viral antibodies is critical in vaccine development. The Structural Biology Section (SBS), of the VRC applies structural biology to the development of an effect HIV-1 vaccine. Despite the vast potential of atomic-level design, current vaccine development does not utilize atomic-level information enough. In order for researchers in the SBS of the VRC to advance their research a Mass Photometer is required to further characterize biomolecules. The Mass Photometer will allow the lab to measure molecular weight of biomolecules, perform direct assessment of protein purity expression and purification, optimize buffer conditions to avoid protein aggregation or promote protein complex assembly and stability, validate protein mono-dispersity to guide, and analyze protein complex assembly to disassembly in a time-resolve manner. The Mass Photometer must meet the following salient characteristics: perform label-free mass measurement of single molecule directly in solution and in native or physiological conditions, utilize interference reflection microscopy and inter-ferometric scattering microscopy technology, perform molecular weight measurement for a variety of biomolecules (glycoproteins, nucleic acids or lipids), compact, bench-top instrument with the dimension less that 500x350x200 mm (WxDxH), wide mass range and high dynamic range and can measure molecular weight ranging from 40 kda to 3 MDa, perform measurement in large concentration range between 10pM to 100nM, perform mass measurement precision of up to 2% of object mass and mass measurement accuracy of up to 3% of object mass, and perform mass analysis to provide homogeneity, mass distribution, and structural integrity. The VRC, SBS laboratory work with a variety of biomolecules, which if the instrument cannot analyze biomolecules (glycoproteins, nucleic acids or lipids) there in no use for the instrumentation. Working with molecules of different sizes and oligomeric states, their molecular weight varies from a few Kda to a million daltons, which the lab requires an instrument that can handle a large range of mass weight for research. The lab requires an instrument that can determine mass weight at very low concentration, since it works with proteins that have different expression levels. Labeling of a protein chain with the chemical composition of a protein that cannot be used as immunogen is time consuming, verses an instrument that can perform label-free, mass measurement of a single molecules directly in solution and in native or physiological conditions. In addition to measurement, the lab needs to analyze the obtained results and provide information on the samples analyzed, especially the homogeneity, mass distribution and integrity of the molecules. Without this function, the instrument will not have the utility. The following factors shall be used to evaluate offerors: technical capability to meet required salient characteristics, 2) warranty, 3) delivery, and 4) price. All responsible sources who can provide the Mass Photometer instrument meeting the requirements of this solicitation may submit a response that could be considered by email (subject line to reference NIAID-RFQ-20-2001482) to Tonia Alexander at contact@example.gov, by 11:00 am eastern standard time (EST) Monday, May 4, 2020. All information furnished must be in writing and must contain sufficient detail to allow NIAID to determine if it can meet the above salient characteristics described herein. By submission of an offer, the Offeror confirms the requirement that a prospective Awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation. Note: Lack of registration in SAM will make an Offeror ineligible for award. Quotes must be received by the reference date of April 4, 2020 and time of 11:00am EST. Any quotation received by NIAID after this date and exact time specified is late and will not be considered.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 811210
New
Federal
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC)
Solicitation # NOI-NIAID-27-2279300
The National Institutes of Health NIAID intends to award a firm-fixed price sole source contract to Revvity Health Sciences, Inc. for a one-year maintenance and service agreement for two Revvity Celigo S imaging instruments. The period of performance is scheduled from November 15, 2026, through November 14, 2027. This procurement is categorized under NAICS code 811210 for electronic and precision equipment repair and maintenance. The government is utilizing statutory authority 41 U.S.C. 3304(a)(1) and FAR 6.302.1(b)(1)(i), asserting that Revvity Health Sciences is the only responsible source capable of satisfying the requirement due to their proprietary access to diagnostic tools, service documentation, and genuine replacement parts. The scope of work includes priority response for unlimited repair travel, labor, and parts, as well as remote support and minor hardware and software updates to ensure the instruments meet manufacturer specifications. While the government intends to negotiate directly with the OEM, interested qualified sources were invited to submit capability statements by November 4, 2026, to the contracting officer, Linda Smith, and acquisition specialist, Jessica Emerson. The final award is expected to be issued within five days of the notice closing.
Electronic and Precision Equipment Repair and Maintenance

POSTED

3 days ago

DEADLINE

in 6 days
View Details
NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

20 days ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS